首页> 外国专利> Icaritin and desmethylicaritin as anti-cancer agents

Icaritin and desmethylicaritin as anti-cancer agents

机译:伊卡立肽和去甲基木蛋白作为抗癌药

摘要

The antiproliferative effects of Icaritin or Desmethylicaritin on cancer cell lines, both in vitro, and in vivo, are disclosed. Experimental data show that Icaritin and Desmethylicaritin dramatically inhibit the growth of most malignant cells. In addition, both Icaritin and Desmethylicaritin have significant Anti-agiogenesis properties, inhibiting or eliminating entirely the development of new malignant cells. Further, no obvious side effects including nausea, hair loss or body weight loss were found in the animals treated with Icaritin or Desmethylicaritin, making both highly effective anti cancer drugs.
机译:公开了伊卡肽素或去甲基二十烷蛋白在体外和体内对癌细胞系的抗增殖作用。实验数据表明,叶番素和去甲基木蛋白能显着抑制大多数恶性细胞的生长。此外,伊卡瑞汀和去甲基木蛋白都具有显着的抗血管生成特性,可以完全抑制或消除新恶性细胞的发育。此外,在用伊卡瑞汀或去甲甲基阿里汀治疗的动物中未发现包括恶心,脱发或体重减轻在内的明显副作用,这两种药物均是非常有效的抗癌药物。

著录项

  • 公开/公告号US2008214844A1

    专利类型

  • 公开/公告日2008-09-04

    原文格式PDF

  • 申请/专利权人 NAN ZHANG;STUART K. CALDERWOOD;

    申请/专利号US20070657214

  • 发明设计人 STUART K. CALDERWOOD;NAN ZHANG;

    申请日2007-01-23

  • 分类号C07D311/30;

  • 国家 US

  • 入库时间 2022-08-21 20:13:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号